Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia: A nationwide surveillance study by the Korean Network for Study on Infectious Diseases (KONSID)

Diagnostic Microbiology and Infectious Disease

Volumn 76, Issue 4, 2013, Pages 477-482

  Huh, Kyungmin ^a   Kim, Jungok ^a   Cho, Sun Young ^a   Ha, Young Eun ^a   Joo, Eun Jeong ^a   Kang, Cheol In ^a   Chung, Doo Ryeon ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a   Peck, Kyong Ran ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bacteremia; Drug resistance; Epidemiology

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE SURVEILLANCE; ENTEROBACTER; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; KOREA; MEDICAL SOCIETY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TREND STUDY;

BACTEREMIA; DRUG RESISTANCE; EPIDEMIOLOGY;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; GENE EXPRESSION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PREVALENCE; REPUBLIC OF KOREA;

EID: 84880762724     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.04.014     Document Type: Article

References (33)

1. Abbo A., Carmeli Y., Navon-Venezia S., Siegman-Igra Y., Schwaber M.J. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 2007, 26:793-800.
2. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
3. Biedenbach D.J., Bell J.M., Sader H.S., Fritsche T.R., Jones R.N., Turnidge J.D. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Int J Antimicrob Agents 2007, 30:143-149.
4. Carmeli Y., Troillet N., Eliopoulos G.M., Samore M.H. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999, 43:1379-1382.
5. Chung D.R., Lee S.S., Lee H.R., Kim H.B., Choi H.J., Eom J.S., et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 2007, 54:578-583.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement (M100-S20). June 2010 Update 2010, CLSI, Wayne, PA.
7. Clinical and Laboratory Standards Institute (CLSI) Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline 2008, CLSI, Wayne, PA. third edition.
8. de Kraker M.E., Jarlier V., Monen J.C., Heuer O.E., van de Sande N., Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect 2012, 10.1111/1469-0691.12028.
9. European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2008. Bilthoven, The Netherlands: EARSS; 2009.
10. Freixas N., Sopena N., Limon E., Bella F., Matas L., Almirante B., et al. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) in acute care hospitals. Results of the VINCat Program (2008-2010). Enferm Infect Microbiol Clin 2012, 30(Suppl. 3):39-42.
11. Fridkin S.K., Steward C.D., Edwards J.R., Pryor E.R., McGowan J.E., Archibald L.K., et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999, 29:245-252.
12. Gales A.C., Sader H.S., Ribeiro J., Zoccoli C., Barth A., Pignatari A.C. Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008). Braz J Infect Dis 2009, 13:90-98.
13. Hadler J.L., Petit S., Mandour M., Cartter M.L. Trends in invasive infection with methicillin-resistant Staphylococcus aureus, Connecticut, USA, 2001-2010. Emerg Infect Dis 2012, 18:917-924.
14. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
15. Hilf M., Yu V.L., Sharp J., Zuravleff J.J., Korvick J.A., Muder R.R. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989, 87:540-546.
16. Jarvis W.R., Jarvis A.A., Chinn R.Y. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 2012, 40:194-200.
17. Kang C.I., Song J.H., Chung D.R., Peck K.R., Ko K.S., Yeom J.S., et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2010, 36:284-287.
18. Kang C.I., Chung D.R., Ko K.S., Peck K.R., Song J.H. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli. Scand J Infect Dis 2011, 43:202-208. Korean Network for the Study of Infectious D.
19. Kang C.I., Song J.H., Chung D.R., Peck K.R., Ko K.S., Yeom J.S., et al. Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect 2011, 62:26-33.
20. Kang C.I., Chung D.R., Ko K.S., Peck K.R., Song J.H. Clinical predictors of Enterobacter bacteremia among patients admitted to the ED. Am J Emerg Med 2012, 30:165-169. Korean Network for Study of Infectious D.
21. Kim N.-H., Hwang J.-H., Song K.-H., Choe P.G., Park W.B., Kim E.S., et al. Changes in antimicrobial susceptibility of blood isolates in a university hospital in South Korea, 1998-2010. Infect Chemother 2012, 44:275-281.
22. Lee K., Kim M.-N., Kim J.-S., Hong H.L., Kang J.O., Shin J.H., et al. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009. Yonsei Med J 2011, 52:793-802.
23. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 2002, 34:634-640.
24. Livermore D.M. Fourteen years in resistance. Int J Antimicrob Agents 2012, 39:283-294.
25. Park C., Lee D.G., Kim S.W., Choi S.M., Park S.H., Chun H.S., et al. Predominance of community-associated methicillin-resistant Staphylococcus aureus strains carrying staphylococcal chromosome cassette mec type IVA in South Korea. J Clin Microbiol 2007, 45:4021-4026.
26. Pena C., Suarez C., Gozalo M., Murillas J., Almirante B., Pomar V., et al. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother 2012, 56:1265-1272.
27. Pfaller M.A., Jones R.N., Doern G.V., Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998, 42:1762-1770.
28. Safdar N., Handelsman J., Maki D.G. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004, 4:519-527.
29. Sievert D.M., Ricks P., Edwards J.R., Schneider A., Patel J., Srinivasan A., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013, 34:1-14.
30. Son J.S., Song J.H., Ko K.S., Yeom J.S., Ki H.K., Kim S.W., et al. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals. J Korean Med Sci 2010, 25:992-998.
31. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995, 274:639-644.
32. World Health Organization (WHO) WHO Global Strategy for Containment of Antimicrobial Resistance 2001, WHO, Geneva, Switzerland.
33. World Health Organization (WHO) Surveillance standards for antimicrobial resistance 2002, WHO, Geneva, Switzerland.